FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/08/035508 [Registered on: 06/08/2021] Trial Registered Prospectively
Last Modified On: 27/07/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Clinical study of three ayurvedic formulations in fungal infection. 
Scientific Title of Study   "CLINICAL EVALUATION OF THE EFFICACY OF ‘PANCHTIKTA GHRITA GUGGUL’, ‘KHADIRARISHTA’ AND ‘EDGAJADI LEPA’ IN DADRU [TAENIA CORPORIS]" 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR Shivani Rawat 
Designation  MD SCHOLAR 
Affiliation  PATANJALI BHARTIYA AYURVIGYAN AVAM ANUSANDHAN SANSTHAN, HARIDWAR 
Address  OPD NO. 12 ,DEPARTMENT OF KAYACHIKITSA, PATANJALI AYURVEDIC HOSPITAL, HARIDWAR

Hardwar
UTTARANCHAL
249405
India 
Phone  8859865042  
Fax    
Email  Shivanirawatofficial@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR ABHISHEK BHUSHAN SHARMA  
Designation  ASSOCIATE PROFESSOR 
Affiliation  PATANJALI BHARTIYA AYURVIGYAN AVAM ANUSANDHAN SANSTHAN, HARIDWAR 
Address  OPD NO. 12, DEPARTMENT OF KAYACHIKITSA ,PATANJALI AYURVEDIC HOSPITAL, HARIDWAR

Hardwar
UTTARANCHAL
249405
India 
Phone  9458636020  
Fax    
Email  ayu.abhishek@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR ABHISHEK BHUSHAN SHARMA  
Designation  ASSOCIATE PROFESSOR 
Affiliation  PATANJALI BHARTIYA AYURVIGYAN AVAM ANUSANDHAN SANSTHAN, HARIDWAR 
Address  OPD NO. 12, DEPARTMENT OF KAYACHIKITSA ,PATANJALI AYURVEDIC HOSPITAL, HARIDWAR

Hardwar
UTTARANCHAL
249405
India 
Phone  9458636020  
Fax    
Email  ayu.abhishek@gmail.com  
 
Source of Monetary or Material Support  
PATANJALI AYURVEDIC HOSPITAL, PATANJALI AYURVIGYAN AVAM ANUSANDHAN SANSTHAN, HARIDWAR 
 
Primary Sponsor  
Name  Patanjali Ayurveda College 
Address  Patanjali Bhartiya Ayurvigyan Avam Anusandhan Sansthan 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SHIVANI RAWAT  PATANJALI AYURVED HOSPITAL  OPD NO. 12, DEPARTMENT OF KAYACHIKITSA, PATANJALI BHARTIYA AYURVIGYAN AVAM ANUSANDHAN SANSTHAN, HARIDWAR, 249405
Hardwar
UTTARANCHAL 
8859865042

Shivanirawatofficial@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PAC/IEC/2019-20/14  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L089||Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: DADRU-KUSHTHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-lepaH (viShopakramaH), लेपः (विषोपक्रमः) (Procedure Reference: Chakradatta 50:36 , Procedure details: Local Application as per requirement)
2Intervention ArmDrugClassical(1) Medicine Name: Panchatikta Ghrita Guggulu, Reference: Chakradatta 50:118-121, Route: Oral, Dosage Form: Guggulu , Dose: 2(NA), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 1 Months, anupAna/sahapAna: Yes(details: Llukewarm Water), Additional Information:
3Intervention ArmDrugClassical(1) Medicine Name: Khadirarishta, Reference: Sharangdhar Samhita Madhyam Khand 10:60-63 1/2, Route: Oral, Dosage Form: Arishta, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 1 Months, anupAna/sahapAna: Yes(details: Water), Additional Information:
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  a) Patient with signs and symptoms of Dadru and taenia corporis were included in the study.
b) Age group above 16 to 60 years randomly included for study.
c) Patients of both sex included for the study.
d) Patients having history of less than two years of onset of disease.
e) Both fresh and treated cases would be taken for the study.
 
 
ExclusionCriteria 
Details  a) Patients under long standing medication.
b) Pregnant women and lactating women.
c) Chronicity more than 2 years.
d) Age group below 16 years and above 60 years.
e) Patient suffering from uncontrolled DM.
f) Patient undergone recent surgeries.
 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Subject Parameter - Grading will be done considering signs and symptoms of dadru- Kandu, Raga,Pidika, Utsannamandal
Objective Parameter-
Size of Mandal is assessed 
Before intervention of the drugs for one month with Panchatikta Ghrita Guggulu and Khadirarishta orally,Edgajadi Lepa locally. 
 
Secondary Outcome  
Outcome  TimePoints 
Subject Parameter - Grading will be done considering signs and symptoms of dadru- Kandu, Raga,Pidika, Utsannamandal
Objective Parameter-
Size of Mandal is assessed 
After intervention of one month with Panchatikta Ghrita Guggulu and Khadirarishta orally,Edgajadi Lepa locally. 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/08/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NOT YET 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

In this trial, we are selecting patient of Dadru (Taenia corporis) in which we will do intervention in single group. We will intervene oral and local administration of ayurvedic drugs (Panchatikta Ghrita Guggulu, Khadirarishta, Edgajadi Lepa). Assessment will be done on basis of subjective & objective parameters.

Dose of medicine- 

Panchatikta Ghrita Guggulu 2 tablets twice daily with luke warm water.

Khadirarishta 20 ml with equal amount of water twice daily.

Edgajadi Lepa  local application.

Route of administration- Panchatikta ghrita guggulu and Khadirarista orally, Edgajadi lepa local application.

Follow-up- The follow up will be done after 15 days and 1 month during the trial of 1 month to observe the effects of treatment or any adverse effects on patient.

 

 

 
Close